WCN24-622 REVEAL-CKD: EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN CHINA

WCN24-622 REVEAL-CKD: EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN CHINA

Saved in:

Bibliographic Details
Main Authors:	Claudia Cabrera, Shiyu Zhou, Mengyun Jia, Shiyu Zhang, Licong Su, Qi Gao, Sheng Nie
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924005953
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in ChinaResearch in context
by: Sheng Nie, et al.
Published: (2025-01-01)

WCN24-1662 EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE (CKD) WITH A GENDER APPROACH IN CHILDREN IN 2 REFERENCE HOSPITALS IN PARAGUAY
by: NIDIA ELIZABETH GOMEZ MOLINAS, et al.
Published: (2024-04-01)

P622: Withdrawn
Published: (2025-01-01)

WCN24-1268 End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)
by: John Sim, et al.
Published: (2024-04-01)

WCN24-1543 PATIENTS’ PERSPECTIVE OF THE IMPACT OF CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD QUALITATIVE STUDY
by: Roberto Pecoits Filho, et al.
Published: (2024-04-01)

WCN24-1204 MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY
by: Ana Flavia Moura, et al.
Published: (2024-04-01)

WCN24-371 TUBERCULOSIS-INDUCED HYPERCALCEMIA IN PREVIOUS STAGE 5 CKD HYPOCALCEMIA: A COMPLEX DIAGNOSTIC DILEMMA
by: Faviola Marie Negrón Alick, et al.
Published: (2024-04-01)

WCN24-1129 CKD-MBD Status in Maintenance Hemodialysis Patients in Bangladesh
by: Farnaz Nobi, et al.
Published: (2024-04-01)

WCN24-2168 PHENOTYPE OF CKD-BMD IN A DIALYSIS POPULATION OF MEXICO
by: Lia Daniela Luna-Navarro, et al.
Published: (2024-04-01)

WCN24-1980 Efficacy and safety of zibotentan in combination with dapagliflozin in patients with CKD according to baseline diabetes status and kidney function
by: Hiddo Lambers Heerspink, et al.
Published: (2024-04-01)

WCN24-1574 HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD PROSPECTIVE STUDY
by: Roberto Pecoits-Filho, et al.
Published: (2024-04-01)

WCN24-332 Single Center Experience of Simultaneous Kidney Pancreas Transplants: Benefit for Type 2 Diabetic CKD Patients
by: Georges Aboukasm, et al.
Published: (2024-04-01)

WCN25-4537 ORAL MANIFESTATIONS IN CHRONIC KIDNEY DISEASES(CKD)
by: Padmini Sirkanungo, et al.
Published: (2025-02-01)

WCN24-244 The utility of Indoxyl sulfate as a biomarker for early detection of CKD
by: Mizuki Hisano, et al.
Published: (2024-04-01)

WCN24-2070 Calprotectin Is Associated with Vascular Calcification and Cardiovascular Complications During CKD
by: Serban Ardeleanu, et al.
Published: (2024-04-01)

GITT Limitations and EIS Insights into Kinetics of NMC622
by: Intizar Abbas, et al.
Published: (2025-06-01)

WCN24-2236 COMPARISON OF FIRST-LINE ANTI-TUBERCULAR DRUGS LEVELS IN TUBERCULOSIS (TB) WITH AND WITHOUT CHRONIC KIDNEY DISEASE (CKD)
by: Divya Datta, et al.
Published: (2024-04-01)

WCN24-343 DECISION-MAKING IN PERSONS WITH END STAGE KIDNEY DISEASE
by: Unini Odama
Published: (2024-04-01)

WCN25-152 HYDRATION: How Much is Suitable in Every CKD Stage?
by: Dmytro Ivanov, et al.
Published: (2025-02-01)

WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients
by: Kushal Kekan, et al.
Published: (2024-04-01)

WCN24-1258 HIGH PREVALENCE OF OSTEOPOROSIS IN ELDERLY PATIENTS WITH ADVANCED CKD: CALL FOR ACTION!
by: Sayuri Kuhnen Hayashi, et al.
Published: (2024-04-01)

WCN24-2388 Prediction model for early-stage CKD using the Naples prognostic score and plasma indoleamine 2,3-dioxygenase activity
by: Hao Hong
Published: (2024-04-01)

WCN24-398 REPORT ON STOP-ACEi TRIAL: REVIEWING CYSTATIN C LEVELS IN CKD PATIENTS
by: Sebastian Spencer, et al.
Published: (2024-04-01)

WCN24-1362 RISK FACTORS INVOLVED IN ERYTHROPOIETIN RESISTANCE IN PATIENTS WITH CKD IN A HEMODIALYSIS UNIT
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

WCN24-2260 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS
by: Vivek Kumar, et al.
Published: (2024-04-01)

WCN24-2178 Risk factors of CKD incidence in Korea NHIS data : Focusing on the influence of diabetes
by: Ki Ryang Na, et al.
Published: (2024-04-01)

WCN24-971 CORRELATION BETWEEN CAROTID, CORONARY AND PERIPHERAL ATHEROSCLEROSIS IN NON-DIALYTIC CKD PATIENTS
by: Erika Carneiro, et al.
Published: (2024-04-01)

WCN24-2145 ACUTE EFFECT OF FERRIC CARBOXYMALTOSE ON OXIDATIVE STRESS IN NON-DIALYSIS CKD PATIENTS
by: Ana Maria Mehedinti, et al.
Published: (2024-04-01)

WCN24-1070 ACUTE KIDNEY INJURY AFTER RENAL SURGERY IN PRE-OPERATIVE ADVANCED CKD PATIENTS: YOU SURE YOU KNOW EVERYTHING?
by: Francesco Trevisani, et al.
Published: (2024-04-01)

WCN24-1604 A CORE OUTCOMES SET FOR TRIALS IN CHRONIC KIDNEY DISEASE: REPORT OF THE STANDARDIZED OUTCOMES IN NEPHROLOGY – CHRONIC KIDNEY DISEASE (SONG-CKD) STAKEHOLDER WORKSHOPS
by: Andrea Matus
Published: (2024-04-01)

WCN25-136 IMPROVE KIDNEY CARE: PERSPECTIVES FROM PEOPLE WITH CKD AND RISK FACTORS FOR CKD ON ACCESS TO AND EXPERIENCE OF NEPHROLOGY SERVICES
by: Rebekah Grace Cheung Judge, et al.
Published: (2025-02-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN24-1630 MORTALITY FROM KIDNEY CANCER IN BRAZIL: AN EPIDEMIOLOGICAL ANALYSIS FROM 2011 TO 2021
by: Geraldo Bezerra da Silva Junior, et al.
Published: (2024-04-01)

Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity.
by: Zhilian Li, et al.
Published: (2014-01-01)

Analysis of Jet Dynamics and Collimation Characteristics of 0241+622 on Parsec Scales
by: Haitian Shang, et al.
Published: (2025-01-01)

WCN24-2678 NEOPLASMS IN KIDNEY TRANSPLANT PATIENTS EPIDEMIOLOGICAL CLINICAL STUDY OF THE HCIPS KIDNEY TRANSPLANT UNIT ASUNCION PARAGUAY
by: Roger Aureliano Ayala Ferrari, et al.
Published: (2024-04-01)

WCN24-2482 COMPARATIVE ANALYSIS OF KIDNEY TRANSPLANTATION IN COUNTRIES WITH HIGHER CKD PREVALENCE IN LATIN AMERICA AND BRAZIL: A RETROSPECTIVE ANALYSIS FROM 2018 TO 2022
by: Camilla Teles, et al.
Published: (2024-04-01)

WCN24-1688 SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS DELINEATED BY CKD STAGE: A REAL-WORLD, MULTI-COUNTRY SURVEY
by: Richard Lafayette, et al.
Published: (2024-04-01)

WCN24-864 Alport Syndrome: genetic variants, phenotypes of kidney disease and association with End Stage Kidney Disease in a Uruguayan Cohort
by: Federico Yandian, et al.
Published: (2024-04-01)

WCN24-746 SUPPLEMENTATION WITH SULFORAPHANE INCREASES NRF2 mRNA EXPRESSION IN NONDIALYSIS CKD PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01)